HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticancer quinones induce pRb-preventable G2/M cell cycle arrest and apoptosis.

Abstract
Reactive oxygen species generated during the metabolism of the antitumor quinone 3,6-diaziridinyl-1,4-benzoquinone (DZQ) in human colonic carcinoma HCT116 cells lead to the induction of p21 (WAF1, Cip1, or sdi1), an upstream regulator of the retinoblastoma gene product pRb involved G1 cell cycle control. We here demonstrate that the cell cycle was arrested in G2/M phase following supplementation with DZQ of human osteosarcoma Saos-2 cells (lacking both p53 and pRb) and HCT116 cells. DZQ also induced p21 and apoptosis in Saos-2 cells. The transfection of the Rb gene into Saos-2 cells did not alter the level of p21 induction, but changed cell cycle arrest into G1 phase and prevented apoptosis. These findings suggest that quinones may lead to a p53-independent and pRb-preventable G2/M arrest and apoptosis, which correlate with p21 induction.
AuthorsX B Qiu, A H Schönthal, E Cadenas
JournalFree radical biology & medicine (Free Radic Biol Med) Vol. 24 Issue 5 Pg. 848-54 (Mar 15 1998) ISSN: 0891-5849 [Print] United States
PMID9586815 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antineoplastic Agents
  • Aziridines
  • Benzoquinones
  • Retinoblastoma Protein
  • ethylenimine quinone
  • Hydrogen Peroxide
Topics
  • Antineoplastic Agents (therapeutic use)
  • Apoptosis (drug effects)
  • Aziridines (therapeutic use)
  • Benzoquinones (therapeutic use)
  • Cell Cycle (drug effects)
  • Drug Screening Assays, Antitumor
  • G2 Phase (drug effects)
  • Humans
  • Hydrogen Peroxide (pharmacology)
  • Mitosis (drug effects)
  • Osteosarcoma (drug therapy, pathology)
  • Retinoblastoma Protein (genetics)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: